The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
March 18th 2025
While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment
April 4, 2025 | New York, NY & Virtual
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
New Mammography Study Reveals Mixed Awareness on Breast Cancer Risks
January 23rd 2023In a new survey that examined perceptions of breast cancer risk among more than 1,800 women who had a recent mammogram, 65 percent noted that being overweight or obese was a greater risk factor than breast density, and over a quarter of those interviewed noted they were not aware that they could reduce their breast cancer risk.
ACR Offers Recommendations for Addressing 'Cost-Prohibitive' IDR Process in Radiology
January 20th 2023Noting the significant administrative fees for the Independent Dispute Resolution (IDR) process of the No Surprises Act and onerous restrictions that have led to a nearly “non-existent” use of batching of disputed claims in radiology, the American College of Radiology (ACR) has sent formal recommendations to the United States Departments of Health and Human Services, Labor, and Treasury for addressing these issues.
Can Multimodal AI Improve Cancer Detection in Dense Breasts?
January 20th 2023Emerging research suggests combined artificial intelligence (AI) assessment of digital mammography and automated 3D breast ultrasound provides enhanced detection of breast cancer in women with dense breasts and may be a viable alternative in areas where radiologists are scarce.
Nine Takeaways from New Article Examining Health Equity in the Radiology Field
January 17th 2023In a provocative new article, radiology researchers discuss the impact of social determinants of health (SDoH) upon access to care and patient outcomes, and present strategies within the realms of radiology education, research, clinical care, and innovation that may help mitigate health-care disparities.
What a New Study Reveals About Breast Density Awareness
January 6th 2023In a recent interview from the Radiological Society of North America (RSNA) conference, Mary Yamashita, M.D. discussed a variety of findings from a survey of over 8,000 women about breast density awareness, challenges with current breast density notification after mammography exams, and the ongoing need to educate patients as well as referring providers on breast density awareness.
Can AI Improve the Consistency of Breast Density Assessment by Radiologists?
December 6th 2022In a recent video interview, Susan Holley, MD discussed key findings from a large retrospective longitudinal study, presented at the recent Radiological Society of North America (RSNA) conference, which found that an emerging artificial intelligence (AI) model was over 24 percent more consistent than radiologist assessment of breast density.
AI Assessment of 3D Digital Breast Tomosynthesis Images May Help Predict Breast Cancer
November 30th 2022An emerging artificial intelligence algorithm, developed to estimate volumetric breast density from 3D-reconstructed digital breast tomosynthesis images, could potentially facilitate individual risk assessments for breast cancer.
Current Insights on AI, Breast Cancer Screening and the FDA
November 8th 2022In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.
Can AI-Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital Mammography?
October 27th 2022In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.